AHCYL1
S-adenosylhomocysteine hydrolase-like protein 1
Also known as: IRBIT, PPP1R78, SAHH2_HUMAN, XPVKONA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43865
- Gene
- AHCYL1
- Ensembl
- ENSG00000168710
- Chromosome
- 1
- Canonical length
- 530 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Cytosol
OverviewNCBI Gene
The protein encoded by this gene interacts with inositol 1,4,5-trisphosphate receptor, type 1 and may be involved in the conversion of S-adenosyl-L-homocysteine to L-homocysteine and adenosine. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
530 residues, UniProt reviewed canonical sequence.
>O43865|AHCYL1
1 MSMPDAMPLP GVGEELKQAK EIEDAEKYSF MATVTKAPKK QIQFADDMQE FTKFPTKTGR
61 RSLSRSISQS STDSYSSAAS YTDSSDDEVS PREKQQTNSK GSSNFCVKNI KQAEFGRREI
121 EIAEQDMSAL ISLRKRAQGE KPLAGAKIVG CTHITAQTAV LIETLCALGA QCRWSACNIY
181 STQNEVAAAL AEAGVAVFAW KGESEDDFWW CIDRCVNMDG WQANMILDDG GDLTHWVYKK
241 YPNVFKKIRG IVEESVTGVH RLYQLSKAGK LCVPAMNVND SVTKQKFDNL YCCRESILDG
301 LKRTTDVMFG GKQVVVCGYG EVGKGCCAAL KALGAIVYIT EIDPICALQA CMDGFRVVKL
361 NEVIRQVDVV ITCTGNKNVV TREHLDRMKN SCIVCNMGHS NTEIDVTSLR TPELTWERVR
421 SQVDHVIWPD GKRVVLLAEG RLLNLSCSTV PTFVLSITAT TQALALIELY NAPEGRYKQD
481 VYLLPKKMDE YVASLHLPSF DAHLTELTDD QAKYLGLNKN GPFKPNYYRYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AHCYL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 236 nTPM
Expression across tissuesHPA
Tissue
- midbrain: 236 nTPM
- choroid plexus: 223 nTPM
- basal ganglia: 204 nTPM
- cerebral cortex: 196 nTPM
- amygdala: 186 nTPM
- hypothalamus: 175 nTPM
Single-cell type
- bergmann glia: 561 nCPM
- astrocytes: 530 nCPM
- endometrial ciliated cells: 311 nCPM
- pancreatic duct cells: 291 nCPM
- somatotrophs: 286 nCPM
- endometrial luminal cells: 248 nCPM
Immune cell
- intermediate monocyte: 5.4 nTPM
- classical monocyte: 5 nTPM
- T-reg: 5 nTPM
- neutrophil: 4.7 nTPM
- eosinophil: 4.6 nTPM
- naive B-cell: 4.4 nTPM
Brain region
- medulla oblongata: 558 nTPM
- spinal cord: 499 nTPM
- thalamus: 480 nTPM
- hypothalamus: 479 nTPM
- midbrain: 458 nTPM
- white matter: 451 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 4.02
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiotensin-activated signaling pathway
- apoptotic process
- epithelial fluid transport
- mitochondrion-endoplasmic reticulum membrane tethering
- one-carbon metabolic process
- positive regulation of sodium ion transport
- protein export from nucleus
- regulation of monoatomic anion transport
- regulation of mRNA 3'-end processing
- response to calcium ion
- S-adenosylmethionine cycle
- regulation of monoatomic ion transmembrane transporter activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AHCYL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AHCYL1 as an antibody target. Whether an autoantibody or antibody against AHCYL1 could matter depends on whether native AHCYL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AHCYL1 is annotated at the cell surface, where native AHCYL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AHCYL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...